2022 annual financial data
Immuneering 2022 Operating margin
Immuneering 2022 operating margin with verified reported values.
Direct answer
Operating margin was -16,325.77%.
Operating income was -51,744,868 USD and net income was -50,513,568 USD.
Operating cash flow was -44,101,265 USD.
Get free Immuneering email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 316,952 USD
- Operating income
- -51,744,868 USD
- Net income
- -50,513,568 USD
- Operating cash flow
- -44,101,265 USD